BioCentury | Feb 21, 2020
Emerging Company Profile

Montis: Exploring an untouched macrophage subset in immuno-oncology

...month. Last week, the VC announced it participated in the $12 million seed round of Volastra Therapeutics Inc....
BioCentury | Feb 12, 2020
Emerging Company Profile

Volastra raises $12M seed led by Polaris to shut down metastasis

...at Weill Cornell Medical College and also co-founded cellular metabolism company Agios Pharmaceuticals Inc. (NASDAQ:AGIO). Volastra Therapeutics Inc.’s...
...board. Volastra is located at JLABS@NYC, Johnson & Johnson’s New York City-based incubator. COMPANY PROFILE Volastra Therapeutics Inc....
Items per page:
1 - 2 of 2
BioCentury | Feb 21, 2020
Emerging Company Profile

Montis: Exploring an untouched macrophage subset in immuno-oncology

...month. Last week, the VC announced it participated in the $12 million seed round of Volastra Therapeutics Inc....
BioCentury | Feb 12, 2020
Emerging Company Profile

Volastra raises $12M seed led by Polaris to shut down metastasis

...at Weill Cornell Medical College and also co-founded cellular metabolism company Agios Pharmaceuticals Inc. (NASDAQ:AGIO). Volastra Therapeutics Inc.’s...
...board. Volastra is located at JLABS@NYC, Johnson & Johnson’s New York City-based incubator. COMPANY PROFILE Volastra Therapeutics Inc....
Items per page:
1 - 2 of 2